Vicore Pharma Holding AB (VCRE) Comparison with companies in other sectors?

Vicore Pharma Holding AB has a share price of 281.53M. You can analyze Vicore Pharma Holding AB (VCRE) competitors across different market sectors through stock heatmaps.

What are VCRE's NET and operating margins?

Vicore Pharma Holding AB (VCRE) operating margin is around N/A, and net profit margin is approximately N/A as of the latest reports.

In what way does VCRE's earnings per share (EPS) trend reflect its financial momentum?

Vicore Pharma Holding AB (VCRE) EPS is N/A (If EPS value is positive, then "signals consistent profit growth" if Negative then "signals consistent loss"). This metric is also critical in assessing valuation metrics like the P/E ratio for Vicore Pharma Holding AB is N/A, and the company's ability to reinvest or distribute profits.

What does a high ROE mean for Vicore Pharma Holding AB?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Vicore Pharma Holding AB like P/E which is N/A, P/B which is N/A, and PEG which is N/A. Compare them with sector averages to evaluate if the stock is priced fairly.

Vicore Pharma Holding AB Fundamental Analysis

VCRE●NASDAQ

HealthcareMedical - Pharmaceuticals

$11.92

$0.48(4.20%)

U.S. Market opens in 17h 15m

Vicore Pharma Holding AB Fundamental Analysis

Vicore Pharma Holding AB (VCRE) shows weak financial fundamentals with a PE ratio of N/A, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.

We analyze VCRE's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

0.0/100

We analyze VCRE's fundamental strength across five key dimensions:

Efficiency Score

Weak

VCRE struggles to generate sufficient returns from assets.

ROA > 10%

N/A

Valuation Score

Weak

VCRE trades at a premium to fair value.

PE < 25

N/A

PEG Ratio < 2

N/A

Growth Score

Weak

VCRE faces weak or negative growth trends.

Revenue Growth > 5%

N/A

EPS Growth > 10%

N/A

Financial Health Score

Weak

VCRE carries high financial risk with limited liquidity.

Debt/Equity < 1

N/A

Current Ratio > 1

N/A

Profitability Score

Weak

VCRE struggles to sustain strong margins.

ROE > 15%

N/A

Net Margin ≥ 15%

N/A

Positive Free Cash Flow

N/A

Key Financial Metrics

Is VCRE Expensive or Cheap?

No data available.

How Well Does VCRE Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How VCRE Stacks Against Its Sector Peers

Metric	VCRE Value	Sector Average	Performance
P/E Ratio	N/A	29.33	N/A
ROE	N/A	426.00%	N/A
Net Margin	N/A	-11441.00% (disorted)	N/A
Debt/Equity	N/A	0.78	N/A
Current Ratio	N/A	5.12	N/A
ROA	N/A	-120.00% (disorted)	N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Vicore Pharma Holding AB's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Vicore Pharma Holding AB Fundamental Analysis

Key Strengths

Areas of Concern

Fundamental Health Score

Efficiency Score

Valuation Score

Growth Score

Financial Health Score

Profitability Score

Key Financial Metrics

Is VCRE Expensive or Cheap?

How Well Does VCRE Make Money?

Following the Money - Real Cash Generation

Financial Ratios Analysis

Valuation Ratios

Financial Health

Efficiency Ratios

How VCRE Stacks Against Its Sector Peers

Historical Growth Performance

5-Year Growth Trajectory

Fundamental Analysis FAQ

Vicore Pharma Holding AB (VCRE) Comparison with companies in other sectors?

What are VCRE's NET and operating margins?

In what way does VCRE's earnings per share (EPS) trend reflect its financial momentum?

What does a high ROE mean for Vicore Pharma Holding AB?

How do I know if AAPL is overvalued or undervalued?